• The Leukemia & Lymphoma Society - The Leukemia & Lymphoma Society is a national voluntary health agency dedicated to curing leukemia, lymphoma, Hodgkin's disease and myeloma, and to improving the quality of life of patients and their families. The Society is committed to attracting and funding outstanding investigators and supports hundreds of researchers doing basic and translational research into cures for leukemia, lymphoma and myeloma.

• Multiple Myeloma Research Foundation (MMRF) - The MMRF is the largest nonprofit foundation dedicated to accelerating the search for a cure for multiple myeloma. Through the building of interdisciplinary collaborations among researchers, pharmaceutical companies, biotech firms, and the National Cancer Institute, the MMRF is expanding therapeutic treatments for myeloma and extending the lives of multiple myeloma patients worldwide.

• International Myeloma Foundation (IMF) - Since 1990, the IMF has supported research on multiple myeloma, including demographic analyses of risk factors for human multiple myeloma. In 1994, the IMF established a research grant program funding both junior and senior investigators. The grants support cutting edge and novel research into better treatment, management, prevention, and ultimately, a cure for myeloma.

• National Cancer Institute (NCI) - The NCI's research programs are extensive and contain many innovative initiatives on cancer, including those targeted to Non-Hodgkins lymphomas of the B-cell lineage and multiple myeloma. Countless specific areas of research are pursued at NCI and by NCI-supported basic and translational scientists throughout the country.